Harold Bernstein, BioMarin CMO
BioMarin recruits Vertex's translational chief to head up clinical trial ops
After spending the last 4 years pushing translational research at the deep science-focused Vertex, Harold Bernstein is making the leap into the clinical world, planting …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.